𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estimation of the treatment effect in a clinical trial when recurrent events define the endpoint

✍ Scribed by Cédric Mahé; Sylvie Chevret


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
89 KB
Volume
18
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

✦ Synopsis


Recurrent events are frequently encountered in clinical trials when individuals may experience an event more than once. Examples are common in medical research, including infectious episodes, myocardial infarctions and hospital admissions. However, when only the "rst event is considered, there is a loss of information. Furthermore, the analysis of recurrent events is complicated by the dependence of the related failure times of each subject, that is, the occurrence of an event in#uences the risk of other events. Thus, naive statistical methods that consider recurrent events as independent observations will produce misleading conclusions. We recommend the use of a marginal hazards model that is derived from the multivariate generalization of the Cox proportional hazards model. This marginal model allows estimation of the relative risk of recurrence in clinical trials, taking into account the dependence between the recurring events of a same individual without explicit modelling. Two applications are used to compare the results of the marginal model analysis with those of usual methods: (i) a placebo-controlled randomized clinical trial performed to evaluate the e$cacy of an immunostimulant in the prevention of recurrences of infectious rhinitis in adults; (ii) a randomized clinical trial comparing transfusions of plasma rich in anti-HIV1 versus transfusions of seronegative plasma in the prevention of opportunist infections. To analyse recurrent events, usual methods are often irrelevant and the marginal model allows use of all the available information to accurately estimate the relative risk of recurrences. Moreover, it enables the estimation of the relative risk for each rank of recurrence.


📜 SIMILAR VOLUMES


Estimating treatment effects in randomiz
✍ Nico Nagelkerke; Vaclav Fidler; Roos Bernsen; Martien Borgdorff 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

In clinical trials where patients are randomized between two treatment arms, not all patients comply with the treatment they were randomly assigned to. The reasons for (non)compliance may be associated with the outcome variable and thereby act as confounders. The standard way of analysing such trial

Analysis of recurrent events: applicatio
✍ Shigeyuki Matsui; Yasuo Ohashi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

This paper discusses the analysis of randomized clinical trials where the primary endpoint is a recurrent event observed during a time period which can vary among patients. In particular it describes a method of estimating robust con"dence limits for clinically relevant parameters. As an illustrativ